Bayer AG - ESG Rating & Company Profile powered by AI
The assessment of Bayer AG incorporates data points from across the web and also from available disclosures by Bayer AG. The page displays a zero-cost E,S&G analysis covering Bayer AG. This ESG score covers 17 United Nations Sustainable Development Goals including: 'Affordable & Clean Energy', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'.
Bayer AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bayer AG | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Bayer AG have an accelerator or VC vehicle to help deliver innovation?
Does Bayer AG disclose current and historical energy intensity?
Does Bayer AG report the average age of the workforce?
Does Bayer AG reference operational or capital allocation in relation to climate change?
Does Bayer AG disclose its ethnicity pay gap?
Does Bayer AG disclose cybersecurity risks?
Does Bayer AG offer flexible work?
Does Bayer AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Bayer AG disclose the number of employees in R&D functions?
Does Bayer AG conduct supply chain audits?
Does Bayer AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Bayer AG conduct 360 degree staff reviews?
Does Bayer AG disclose the individual responsible for D&I?
Does Bayer AG disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Bayer AG disclose current and / or historical scope 2 emissions?
Does Bayer AG disclose water use targets?
Does Bayer AG have careers partnerships with academic institutions?
Did Bayer AG have a product recall in the last two years?
Does Bayer AG disclose incidents of discrimination?
Does Bayer AG allow for Work Councils/Collective Agreements to be formed?
Has Bayer AG issued a profit warning in the past 24 months?
Does Bayer AG disclose parental leave metrics?
Does Bayer AG disclose climate scenario or pathway analysis?
Does Bayer AG disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Bayer AG disclose the pay ratio of women to men?
Does Bayer AG support suppliers with sustainability related research and development?
Does Bayer AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Bayer AG reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Bayer AG involved in embryonic stem cell research?
Does Bayer AG disclose GHG and Air Emissions intensity?
Does Bayer AG disclose its waste policy?
Does Bayer AG report according to TCFD requirements?
Does Bayer AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Bayer AG disclose energy use targets?
Does Bayer AG disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Bayer AG have a policy relating to cyber security?
Have a different question?
Potential Risks for Bayer AG
These potential risks are based on the size, segment and geographies of the company.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.